Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Eczema, Rosacea
Clinical narrative: pain in my shoulder joint; eczema; rosacea; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Nov2022 at 10:15 as dose 4 (booster), single (Lot number: GH9703) at the age of 51 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Osteoporosis" (unspecified if ongoing); "Colitis" (unspecified if ongoing); "SIBO" (unspecified if ongoing); "Sucrase deficiency" (unspecified if ongoing); "mild lumbar / hip arthritis and cervical stenosis" (unspecified if ongoing); "mild lumbar / hip arthritis and cervical stenosis" (unspecified if ongoing); "mild lumbar / hip arthritis and cervical stenosis" (unspecified if ongoing); "frozen shoulder right side" (unspecified if ongoing); "Known allergies: brazil nuts" (unspecified if ongoing); "Known allergies: fire ants" (unspecified if ongoing); "Known allergies: bees" (unspecified if ongoing); "Eczema" (not ongoing), notes: Prior to the vaccine, my eczema and rosacea had been completely clear for approximately 2 months; "rosacea" (not ongoing), notes: Prior to the vaccine, my eczema and rosacea had been completely clear for approximately 2 months. Concomitant medication(s) included: ALENDRONATE; PREMPRO; BIOCIDIN; THYROSTIM. Past drug history included: Codeine, reaction(s): "Known allergies: Codeine". Vaccination history included: BNT162b2 (DOSE 3 (BOOSTER), SINGLE, lot number: FF2588), administration date: 21Dec2021, when the patient was 50-year-old, for COVID-19 immunization; BNT162b2 (DOSE 2, SINGLE, lot number: ER8733, vaccine location: Left arm), administration date: 17Apr2021, when the patient was 49-year-old, for COVID-19 immunization; BNT162b2 (DOSE 1, SINGLE, lot number: EN6207, vaccine location: Left arm), administration date: 27Mar2021, when the patient was 49-year-old, for COVID-19 immunization; typhoid (DOSE 1, SINGLE, vaccine location: left arm), administration date: 31Oct2022, when the patient was 51-year-old, for Immunization; hepatitis b (DOSE 1, SINGLE, vaccine location: left arm), administration date: 31Oct2022, when the patient was 51-year-old, for Immunization; influenza (DOSE 1, SINGLE, vaccine location: left arm), administration date: 31Oct2022, when the patient was 51-year-old, for Immunization. The following information was reported: ARTHRALGIA (non-serious) with onset 13Nov2022 at 18:00, outcome "recovered", described as "pain in my shoulder joint"; ECZEMA (non-serious) with onset Nov2022, outcome "unknown"; ROSACEA (non-serious) with onset Nov2022, outcome "unknown". Therapeutic measures were not taken as a result of arthralgia, eczema, rosacea.  Clinical course: Prior to the vaccine, my excema and rosacea had been completely clear for approximately 2 months. About 5 days after the vaccination, they reoccured. Coincidentally, I saw my dermatologist on Day 3, and she saw no rosacea or excema. Also starting on Day 5, I began to have pain in my shoulder joint (unlike the original injection-site pain), and it is worsening. Seems like it may be the beginning of frozen shoulder (which I just had on my right side which is now fully resolved). Prior to this, I had no issues at all with my left shoulder. I have written to my Orthopedist and will contact my primary care doc (who administered the other vaccines noted above on 31Oct) in the AM. Facility type vaccine: Pharmacy or Drug Store. The patient was not diagnosed with COVID-19 before vaccination, and the patient was not tested for COVID-19 post vaccination.